The renewed arrangement will see Cognizant combine its life sciences sector knowledge with technical services to aid Gilead’s ongoing development and operational processes. The joint work is intended
The post Gilead Sciences signs five-year DevOps agreement with Cognizant appeared first on Pharmaceutical Business review.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.